The impetus for this pharmacy-therapy treatment stemmed from research on pharmaco-systems in DAT. Albert et al. (1988) found that when a patient with nonfluent aphasia was given bromocriptine, he performed better on language tests than when he was not medicated. The limited success of this pilot study highlights the advantages that an integration of research from DAT and aphasia will provide.